|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-4266 |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...UAAUCUUG
CUCCUAA
U... 3' CCGGUUCCG GAGGAU C |
7mer-A1 | 1281-1287 | -0.392 | 97.0 | -0.392 | 98.0 | noncon | |
5'...AGCCACCU
CCUCCUAA
... 3' CCGGUUCC GGAGGAU C |
8mer | 5416-5423 | -0.393 | 97.0 | -0.393 | 98.0 | noncon | |
5'...CUCCGCUG
CCUCCUA
C... 3' CCGGUUCC GGAGGAU C |
7mer-m8 | 1170-1176 | -0.179 | 78.0 | -0.179 | 86.0 | noncon |